Imaging Cell Line

  • LS-174T/GFP-firefly luciferase (CMV)  stable cells
    LS-174T/GFP-firefly luciferase (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter.
    Price: $2,350.00
  • LS-174T/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    LS-174T/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/GFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically GFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • LS-174T/HSV1-tk (CMV)  stable cells
    LS-174T/HSV1-tk (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $1,350.00
  • LS-174T/HSV1-tk-firefly luciferase (CMV)  stable cells
    LS-174T/HSV1-tk-firefly luciferase (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $2,350.00
  • LS-174T/RFP (CMV)  stable cells
    LS-174T/RFP (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $1,350.00
  • LS-174T/RFP-firefly luciferase (CMV)  stable cells
    LS-174T/RFP-firefly luciferase (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The cells proliferation and trafficing could be imaged with fluorescence imaging in xenograft model.
    Price: $2,350.00
  • LS-174T/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    LS-174T/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells
    LS-174T, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LS-174T/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • MCF7/firefly luciferase (CMV)  stable cells
    MCF7/firefly luciferase (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficking of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.

    Price: $1,350.00
  • MCF7/GFP (CMV)  stable cells
    MCF7/GFP (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/GFP (CMV) stable cells express transgenically GFP under the control of the CMV promoter. The proliferation and trafficking of the cells could be monitored in fluorescence imaging in small animal xenograft model.

    Price: $1,350.00
  • MCF7/GFP-firefly luciferase (CMV)  stable cells
    MCF7/GFP-firefly luciferase (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/GFP-firefly luciferase (CMV) stable cells express transgenically GFP and firefly luciferase under the control of the CMV promoter. The proliferation and trafficking of the cells could be monitored in fluorescence imaging in small animal xenograft model.

    Price: $2,350.00
  • MCF7/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    MCF7/GFP-firefly luciferase-HSV1-tk (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/GFP-firefly luciferase-HSV1-tk  (CMV) stable cells express transgenically GFP, firefly luciferase and HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescence and PET.

    Price: $3,350.00
  • MCF7/HSV1-tk (CMV)  stable cells
    MCF7/HSV1-tk (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/HSV1-tk  (CMV) stable cells express transgenically GFP, firefly luciferase and HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with PET imaging.

    Price: $1,350.00
  • MCF7/HSV1-tk-firefly luciferase (CMV)  stable cells
    MCF7/HSV1-tk-firefly luciferase (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/HSV1-tk-firefly luciferase stable cells express transgenically HSV1-tk and firefly luciferase under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with bioluminescence and  PET imaging.

    Price: $2,350.00
  • MCF7/RFP (CMV)  stable cells
    MCF7/RFP (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/RFP stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.

    Price: $1,350.00
  • MCF7/RFP-firefly luciferase (CMV)  stable cells
    MCF7/RFP-firefly luciferase (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/RFP-firefly luciferase stable cells express transgenically RFP and firefly luciferase under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence and  bioluminescence imaging.

    Price: $2,350.00
  • MCF7/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    MCF7/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells

    MCF-7 is one of the most commonly used human breast cancer cell lines in research. Derived from the pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer, MCF-7 cells express estrogen receptors (ER) and are hormone-sensitive. This makes them a critical model for studying hormone-responsive breast cancer, particularly in understanding the role of estrogen in cancer cell proliferation and survival. Researchers often use MCF-7 cells to investigate the effects of endocrine therapies, such as tamoxifen, which blocks estrogen receptors. These cells also respond to progesterone and other hormones, making them an excellent system for exploring various aspects of hormone receptor signaling. Cells exhibit some features of differentiated mammary epithelium including oestradiol synthesis and formation of domes, which help mimic the tumor environment. Growth of MCF-7 cells is inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can be modulated by treatment with anti-estrogens.

    MCF-7 has been widely used in cancer research and drug development in vitro and in vivo. Studies with MCF-7 cells contribute to the understanding of breast cancer progression, drug resistance mechanisms, and the development of hormone-based cancer treatments.

    MCF7/RFP-firefly luciferase-HSV1-tk stable cells express transgenically RFP and firefly luciferase and HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence and  bioluminescence and PET imaging.

    Price: $3,350.00
  • MDA-MB-231/firefly luciferase (CMV)  stable cells
    MDA-MB-231/firefly luciferase (CMV) stable cells
    MDA-MB-231, a human breast cancer cell line, has been widely used in cancer research and drug development in vitro and in vivo. MDA-MB-231/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.
    Price: $3,200.00
  • MDA-MB-231/GFP (CMV)  stable cells
    MDA-MB-231/GFP (CMV) stable cells
    MDA-MB-231, a human breast cancer cell line, has been widely used in cancer research and drug development in vitro and in vivo. MDA-MB-231/GFP (CMV) stable cells express transgenically GFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $3,200.00
  • MDA-MB-231/GFP-firefly luciferase (CMV)  stable cells
    MDA-MB-231/GFP-firefly luciferase (CMV) stable cells
    MDA-MB-231, a human breast cancer cell line, has been widely used in cancer research and drug development in vitro and in vivo. MDA-MB-231/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter.
    Price: $4,200.00
  • MDA-MB-231/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    MDA-MB-231/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    MDA-MB-231, a human breast cancer cell line, has been widely used in cancer research and drug development in vitro and in vivo. MDA-MB-231/GFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically GFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $5,200.00
Loading...